PhageLine #5: The LNT103 engineered endolysin for Gram-negative pathogens
Manage episode 468336940 series 3648800
Welcome to PhageLine. This week we will focus on using specific phage proteins called endolysins instead of whole phages to fight bacteria by discussing the in vitro and in vivo efficacy of an engineered endolysin targeting Gram-negative pathogens. Have fun!
This episode was generated using artificial intelligence. An infectious disease researcher reviewed the contents of the episode.
32 епізодів